Skip to main content
. 2014 Jul 15;111(5):883–893. doi: 10.1038/bjc.2014.387

Table 2. Relationship between HOXB9 expression and various clinicopathological factors in patients with colon adenocarcinoma (n=63).

Characteristic Low-expression group High-expression group Statistic method P
 
28
44.44%
35
55.56%
 
 
Sex
 
 
 
 
χ2
0.63
Male
16
25.40%
18
28.57%
 
 
Female
12
19.05%
17
26.98%
 
 
Tumour Nodes Metastases category
T1-2 1 1.59% 4 6.35% Fisher's exact test 0.3707
T3-4 27 26.98% 31 65.08%    
N0 16 25.40% 24 38.10% χ2 0.5456
N1-2 11 17.46% 12 19.05%    
M0 26 41.27% 35 55.56% χ2 correction for continuity 0.3768
M1
2
3.17%
0
0.00%
 
 
American Joint Committee on Cancer
I 0 0.00% 3 4.76% Fisher's exact test 0.2092 0.3294
II 17 26.98% 20 31.75%    
III 9 14.29% 12 19.05% Kruskal–Walls test 0.1811  
IV
2
3.17%
0
0.00%
Spearman's correlation coefficient −0.12490
 
Differentiation
Poorly differentiation 9 14.29% 4 6.35% Spearman's correlation coefficient 0.26595 0.0436*
Moderate differentiation 17 26.98% 20 31.75% Fisher's exact test 0.1432  
Well differentiation 2 3.17% 6 9.52% Kruskal–Walls test 0.1332  
Tubular like 8 12.70% 22 34.92% χ2 0.0068*
Sieve like
20
31.75%
13
20.63%
 
 
Survival status
Alive 12 19.05% 24 38.10% χ2 0.0404*
Dead
16
25.40%
11
17.46%
 
 
  *Significant P-value, P⩽0.05

Methods including χ2, Fisher's exact test and Spearman's correlation coefficient were used to analyse the correlation between HOXB9 expression and clinicopathological characteristics of patients with colon adenocarcinoma. AJCC is a classification system developed by the American Joint Committee on Cancer.